Investing in the
forefront of RLT supply
chain Excellence

A scientific leader readily positioned to take advantage of the change in the landscape of cancer treatment

Our Investment Case

1

SECURED MATERIAL ACCESS

Rocket Isotopes has already secured access to raw materials and irradiation facilities, while conducting in-house purification and quality control

2

UNIQUE SCIENTIFIC KNOW-HOW

Rocket Isotopes is one of the few companies worldwide with the capabilities and know-how to produce Tb-161 at scale

3

MARKET UPSIDE POTENTIAL

Rocket Isotopes offers a unique opportunity to invest into the forefront of supply chain excellence in a high-growth RLT segment revolutionizing cancer therapy globally.

4

SYNERGETIC SUPPLY EXCLUSIVITY

The company will initially operate as the supplier of Torpedo, and as such have a secure, exclusive revenue channel as the sole supplier of Tb-161 raw materials.

Contact Investor Relations

For Investment inquiries, Please Contact: